thiazoles has been researched along with panobinostat in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czyz, M; Jakubowska, J | 1 |
| Chae, JI; Cho, JH; Jeon, YJ; Ko, SM; Shim, JH | 1 |
| Orlowski, RZ | 1 |
| Damania, B; Dittmer, DP; Frye, S; Hopcraft, SE; James, LI; Pattenden, SG | 1 |
| Bargou, RC; Brünnert, D; Chatterjee, M; Driessen, C; Goyal, P; Heiden, R; Kirner, S; Kraus, M; Stühmer, T | 1 |
2 review(s) available for thiazoles and panobinostat
| Article | Year |
|---|---|
[Novel inhibitors of Bcr-Abl].
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Benzamides; Dasatinib; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Hydroxamic Acids; Imatinib Mesylate; Indoles; Inhibitory Concentration 50; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Molecular Structure; Mutation; Panobinostat; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyridones; Pyrimidines; Thiazoles | 2006 |
Novel agents for multiple myeloma to overcome resistance in phase III clinical trials.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunologic Factors; Indoles; Multiple Myeloma; Oligopeptides; Panobinostat; Phosphorylcholine; Piperidines; Proteasome Inhibitors; Pyridines; Remission Induction; Thalidomide; Thiazoles; Treatment Outcome; Vorinostat | 2013 |
3 other study(ies) available for thiazoles and panobinostat
| Article | Year |
|---|---|
The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Indoles; Mouth Neoplasms; Panobinostat; Signal Transduction; Sp1 Transcription Factor; Tetrazolium Salts; Thiazoles | 2013 |
Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency.
Topics: Cell Line; Chromatin Assembly and Disassembly; Depsipeptides; Epigenesis, Genetic; Genome, Viral; Herpesvirus 8, Human; Heterocyclic Compounds, 2-Ring; Histone Deacetylase Inhibitors; Host-Pathogen Interactions; Humans; Immediate-Early Proteins; Panobinostat; Polycomb Repressive Complex 1; Promoter Regions, Genetic; RNA Interference; Thiazoles; Trans-Activators; Virus Activation; Virus Latency | 2018 |
Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma.
Topics: A549 Cells; Amino Acid Substitution; Antineoplastic Agents; Boron Compounds; Bortezomib; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression; Glycine; Histone Deacetylases; Humans; Indoles; Models, Biological; Multiple Myeloma; Mutation; Oligopeptides; Panobinostat; Phosphatidylinositol 3-Kinase; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrimidines; Thiazoles | 2019 |